CHEMIDEX PHARMA LIMITED
Get an alert when CHEMIDEX PHARMA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£2m
-16.1% lowest in 5 filed years
Net assets
£52m
+21.8% highest in 5 filed years
Employees
63
+28.6% highest in 5 filed years
Profit before tax
£9.3m
+68.7% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
Accordingly, while the Directors consider it appropriate to prepare the financial statements on a going concern basis, these conditions indicate the existence of a material uncertainty which may cast significant doubt on the Company's ability to continue as a going concern.
-
Going-concern uncertainty disclosed
Net assets
5-year trend · vs Health Care median
Accounts
5-year trend · Δ = latest vs prior filed period · latest reflected 2025-06-30
| Metric | Trend | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | Δ vs prior |
|---|---|---|---|---|---|---|---|
| Turnover | £33,000,551 | £30,681,464 | £28,630,454 | £26,397,660 | £25,731,754 | -2.5% | |
| Operating profit | £15,500,705 | £25,654,108 | £8,029,783 | £3,567,542 | £6,652,993 | +86.5% | |
| Profit before tax | £16,217,306 | £26,860,273 | £10,008,012 | £5,497,219 | £9,272,806 | +68.7% | |
| Net profit | — | — | £8,638,855 | £5,837,564 | £9,170,666 | +57.1% | |
| Cash | £12,716,273 | £8,209,459 | £3,002,926 | £2,418,625 | £2,029,545 | -16.1% | |
| Total assets less current liabilities | £16,525,101 | £28,186,252 | £36,961,999 | £47,900,533 | £52,386,774 | +9.4% | |
| Net assets | £16,363,810 | £28,024,961 | £36,850,225 | £42,893,583 | £52,234,589 | +21.8% | |
| Equity | £16,363,810 | £28,024,961 | £36,850,225 | £42,893,583 | £52,234,589 | +21.8% | |
| Average employees | 26 | 33 | 43 | 49 | 63 | +28.6% | |
| Wages | — | — | £3,244,154 | £4,346,511 | £4,904,077 | +12.8% | |
| Directors' remuneration | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|---|---|
| Operating margin | 47.0% | 83.6% | 28.0% | 13.5% | 25.9% | |
| Net margin | — | — | 30.2% | 22.1% | 35.6% | |
| Return on capital employed | 93.8% | 91.0% | 21.7% | 7.4% | 12.7% | |
| Gearing (liabilities / total assets) | — | — | — | 54.6% | 53.9% | |
| Current ratio | — | — | 1.99x | 2.01x | 1.84x | |
| Interest cover | — | — | — | 6.96x | 23.50x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- CHEMIDEX PHARMA LIMITED 2000-11-22 → present
- HAVENSTORE LIMITED 1982-11-08 → 2000-11-22
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Accordingly, while the Directors consider it appropriate to prepare the financial statements on a going concern basis, these conditions indicate the existence of a material uncertainty which may cast significant doubt on the Company's ability to continue as a going concern.”
Group structure
- CHEMIDEX PHARMA LIMITED · parent
- Essential Pharma Switzerland GmbH 100%
Significant events
- “Subsequent to the period end, on 7 January 2026, the Company acquired the entire issued share capital of Polantra Limited, a supplier of specialist pharmaceutical products, for total cash consideration of £31.0m. This acquisition was funded in full through the issue of additional equity shares by the Company's ultimate parent company, Elysium Topco Limited, to Elysium Acquisition L.P.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| RAMSDEN, Simon Stanley, Mr. | Director | 2025-09-29 | Dec 1981 | British |
| WEBB, Andrew Michael, Mr. | Director | 2022-05-01 | Jun 1983 | British |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ENGINEER, Misha | Secretary | 2013-03-27 | 2014-10-17 |
| ENGINEER, Navinchandra Jamnadas | Secretary | — | 2013-03-28 |
| ASH, Benjamin Matthew | Director | 2020-04-17 | 2025-06-27 |
| ENGINEER, Misha | Director | 2013-03-15 | 2014-10-17 |
| ENGINEER, Navinchandra Jamnadas | Director | — | 2013-03-28 |
| ENGINEER, Nikesh | Director | 2012-11-02 | 2021-06-22 |
| ENGINEER, Varsha Navinchandra | Director | — | 2013-03-28 |
| JOHNSON, Emma Jane | Director | 2023-07-01 | 2025-11-10 |
| LIBORG, Ingvild | Director | 2020-04-17 | 2022-04-30 |
| VANGSGAARD, Steen | Director | 2021-06-22 | 2023-06-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Cortex 3 Guernsey Limited | Corporate entity | Shares 25–50% | 2019-12-16 | Ceased 2019-12-16 |
| Guy Semmens | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-16 | Active |
| Mr Navinchandra Jamnadas Engineer | Individual | Shares 50–75% | 2016-04-06 | Ceased 2019-12-16 |
| Mrs Varsha Navinchandra Engineer | Individual | Shares 25–50% | 2016-04-06 | Ceased 2019-12-16 |
Filing timeline
Last 20 of 165 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-07-10 | AA | accounts | Accounts with accounts type full | |
| 2025-11-27 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-30 | AP01 | officers | Appoint person director company with name date | |
| 2025-07-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-08 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-02 | AA | accounts | Accounts with accounts type full | |
| 2025-04-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-04-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-12-11 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-11 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-11 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-12-11 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-09-13 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2024-07-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-15 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-03-27 | AA | accounts | Accounts with accounts type full | |
| 2024-03-05 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-02-23 | RP04PSC01 | persons-with-significant-control | Second filing notification of a person with significant control | |
| 2023-07-18 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.